en
Scientific article
English

Impact of rivaroxaban on point-of-care assays

Published inThrombosis research, vol. 153, p. 65-70
Publication date2017
Abstract

Point-of-care testing (POCT) is regularly used to assess haemostasis in various clinical settings. The impact of rivaroxaban on those POCT is still elusive. We aimed to study the effects of rivaroxaban on most commonly used POCT assays.

Citation (ISO format)
FONTANA, Pierre et al. Impact of rivaroxaban on point-of-care assays. In: Thrombosis research, 2017, vol. 153, p. 65–70. doi: 10.1016/j.thromres.2017.03.019
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0049-3848
392views
0downloads

Technical informations

Creation04/21/2017 3:54:00 PM
First validation04/21/2017 3:54:00 PM
Update time03/15/2023 1:41:48 AM
Status update03/15/2023 1:41:47 AM
Last indexation01/16/2024 11:58:19 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack